Search Within

Noushin Rahnamay Farnoud

Formats
  1. Journal Article (26)
  2. Meeting Abstract (22)
  3. Research Letter (3)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Department of Medicine (41)
  3. Hematologic Malignancies, Division of (39)
  4. Adult Leukemia (38)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (29)
  6. Executive Committee, Center for Hematologic Malignancies (29)

More Groups

People
  1. Raajit Rampal (24)
  2. Elli Papaemmanuil (21)
  3. Ross Levine (21)
  4. Erin McGovern (16)
  5. Juan Arango Ossa (16)
  6. Juan Medina (15)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Blood (24)
  2. Blood Advances (5)
  3. Clinical Cancer Research (3)
  4. Cancer Cell (2)
  5. Cancer Discovery (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (4)
  4. Cell Press (2)
  5. Amer Soc Clinical Investigation Inc (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
    Journal Article

    Marcellino, B. K.; Farnoud, N.; Cassinat, B.; Lu, M.; Verger, E.; McGovern, E.; Patel, M.; Medina-Martinez, J.; Levine, M. F.; Arango Ossa, J. E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
    Journal Article

    Mascarenhas, J. O.; Rampal, R. K.; Kosiorek, H. E.; Bhave, R.; Hexner, E.; Wang, E. S.; Gerds, A.; Abboud, C. N.; Kremyanskaya, M.; Berenzon, D.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Evaluating clonal hematopoiesis in tumor-infiltrating leukocytes in breast cancer and secondary hematologic malignancies
    Journal Article

    Comen, E. A.; Bowman, R. L.; Selenica, P.; Kleppe, M.; Farnoud, N. R.; Pareja, F.; Weigelt, B.; Hill, C. E.; Alon, A.; Geyer, F. C.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • The genetic architecture of myeloproliferative neoplasms-blast phase (MPN-BP) stem cells
    Meeting Abstract

    Wang, X.; Rampal, R. K.; Hu, C. S.; Farnoud, N.; Famulare, C.; Patel, M. A.; McGovern, E.; Hoffman, R.
    Blood (2019)

    Fulltext@MSK | Save
  • Significance of abnormalities of PPM1D in myeloproliferative neoplasms
    Meeting Abstract

    Marcellino, B.; Tripodi, J.; Bar-Natan, M.; Fruchtman, H.; Farnoud, N.; Lu, M.; Kosiorek, H. E.; Dueck, A. C.; Rampal, R. K.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Expansion of prior existing TP53 mutated clones in polycythemia vera patients treated with idasanutlin
    Meeting Abstract

    Marcellino, B.; Cassinat, B.; Farnoud, N.; Lu, M.; Verger, E.; McGovern, E.; Patel, M. A.; Kosiorek, H. E.; Mehrotra, M.; Houldsworth, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
    Research Letter

    Mascarenhas, J.; Kosiorek, H.; Prchal, J.; Yacoub, A.; Berenzon, D.; Baer, M. R.; Ritchie, E.; Silver, R. T.; Kessler, C.; Winton, E.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
    Journal Article

    Yacoub, A.; Mascarenhas, J.; Kosiorek, H.; Prchal, J. T.; Berenzon, D.; Baer, M. R.; Ritchie, E.; Silver, R. T.; Kessler, C.; Winton, E.; more...
    Blood (2019)

    Fulltext@MSK | Save